Annual CFO
-$45.63 M
-$13.55 M-42.25%
December 31, 2023
Summary
- As of February 26, 2025, BCAX annual cash flow from operations is -$45.63 million, with the most recent change of -$13.55 million (-42.25%) on December 31, 2023.
- During the last 3 years, BCAX annual CFO has fallen by -$13.55 million (-42.25%).
- BCAX annual CFO is now -42.25% below its all-time high of -$32.08 million, reached on December 31, 2022.
Performance
BCAX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$17.22 M
NaN%
September 30, 2024
Summary
- As of February 26, 2025, BCAX quarterly cash flow from operations is -$17.22 million
- BCAX quarterly CFO is now -63.54% below its all-time high of -$10.53 million, reached on September 30, 2023.
Performance
BCAX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$17.22 M
NaN%
September 30, 2024
Summary
- As of February 26, 2025, BCAX TTM cash flow from operations is -$17.22 million
- BCAX TTM CFO is now -63.54% below its all-time high of -$10.53 million, reached on September 30, 2023.
Performance
BCAX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BCAX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.3% | - | - |
| 3 y3 years | -42.3% | - | - |
| 5 y5 years | -42.3% | - | - |
BCAX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.3% | at low | -63.5% | at low | -63.5% | at low |
| 5 y | 5-year | -42.3% | at low | -63.5% | at low | -63.5% | at low |
| alltime | all time | -42.3% | at low | -63.5% | at low | -63.5% | at low |
Bicara Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.22 M(+63.5%) | -$17.22 M(+63.5%) |
| Dec 2023 | -$45.63 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$10.53 M | -$10.53 M |
| Dec 2022 | -$32.08 M | - | - |
FAQ
- What is Bicara Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Bicara Therapeutics?
- What is Bicara Therapeutics annual CFO year-on-year change?
- What is Bicara Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bicara Therapeutics?
- What is Bicara Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Bicara Therapeutics?
What is Bicara Therapeutics annual cash flow from operations?
The current annual CFO of BCAX is -$45.63 M
What is the all time high annual CFO for Bicara Therapeutics?
Bicara Therapeutics all-time high annual cash flow from operations is -$32.08 M
What is Bicara Therapeutics annual CFO year-on-year change?
Over the past year, BCAX annual cash flow from operations has changed by -$13.55 M (-42.25%)
What is Bicara Therapeutics quarterly cash flow from operations?
The current quarterly CFO of BCAX is -$17.22 M
What is the all time high quarterly CFO for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly cash flow from operations is -$10.53 M
What is Bicara Therapeutics TTM cash flow from operations?
The current TTM CFO of BCAX is -$17.22 M
What is the all time high TTM CFO for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM cash flow from operations is -$10.53 M